RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Stryker Stock

Stryker Revenue 2024

Stryker Revenue

22.82 B USD

Ticker

SYK

ISIN

US8636671013

WKN

864952

In 2024, Stryker's sales reached 22.82 B USD, a 11.31% difference from the 20.5 B USD sales recorded in the previous year.

The Stryker Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e29.4244,52
2027e28.0146,77
2026e26.5849,27
2025e24.6753,10
2024e22.8257,41
202320.563,90
202218.4563,08
202117.1164,30
202014.3563,81
201914.8865,85
201813.666,03
201712.4466,37
201611.3366,71
20159.9566,38
20149.6865,70
20139.0266,72
20128.6668,14
20118.3166,16
20107.3268,77
20096.7267,51
20086.7268,28
2007668,91
20065.1568,60
20054.6167,69
20044.0267,56

Stryker Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Stryker, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Stryker from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Stryker’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Stryker. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Stryker’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Stryker’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Stryker’s growth potential.

Stryker Revenue, EBIT and net profit per share

DateStryker RevenueStryker EBITStryker Net Income
2028e29.42 B undefined8.08 B undefined6.34 B undefined
2027e28.01 B undefined7.55 B undefined6.04 B undefined
2026e26.58 B undefined7.06 B undefined5.74 B undefined
2025e24.67 B undefined6.43 B undefined5.21 B undefined
2024e22.82 B undefined5.72 B undefined4.64 B undefined
202320.5 B undefined4.38 B undefined3.17 B undefined
202218.45 B undefined3.75 B undefined2.36 B undefined
202117.11 B undefined3.5 B undefined1.99 B undefined
202014.35 B undefined2.95 B undefined1.6 B undefined
201914.88 B undefined3.38 B undefined2.08 B undefined
201813.6 B undefined3.09 B undefined3.55 B undefined
201712.44 B undefined2.77 B undefined1.02 B undefined
201611.33 B undefined2.58 B undefined1.65 B undefined
20159.95 B undefined2.26 B undefined1.44 B undefined
20149.68 B undefined2.2 B undefined515 M undefined
20139.02 B undefined2.09 B undefined1.01 B undefined
20128.66 B undefined2.26 B undefined1.3 B undefined
20118.31 B undefined1.76 B undefined1.35 B undefined
20107.32 B undefined1.88 B undefined1.27 B undefined
20096.72 B undefined1.66 B undefined1.11 B undefined
20086.72 B undefined1.55 B undefined1.15 B undefined
20076 B undefined1.33 B undefined1.02 B undefined
20065.15 B undefined1.12 B undefined778 M undefined
20054.61 B undefined948 M undefined644 M undefined
20044.02 B undefined799 M undefined440 M undefined

Stryker stock margins

The Stryker margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stryker. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stryker.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Stryker's sales revenue. A higher gross margin percentage indicates that the Stryker retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Stryker's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Stryker's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Stryker's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Stryker. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Stryker's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Stryker Margin History

Stryker Gross marginStryker Profit marginStryker EBIT marginStryker Profit margin
2028e63.9 %27.45 %21.54 %
2027e63.9 %26.95 %21.56 %
2026e63.9 %26.57 %21.59 %
2025e63.9 %26.08 %21.12 %
2024e63.9 %25.08 %20.34 %
202363.9 %21.35 %15.44 %
202263.08 %20.3 %12.78 %
202164.3 %20.46 %11.66 %
202063.81 %20.54 %11.14 %
201965.85 %22.72 %13.99 %
201866.03 %22.7 %26.12 %
201766.37 %22.24 %8.2 %
201666.71 %22.75 %14.54 %
201566.38 %22.69 %14.47 %
201465.7 %22.72 %5.32 %
201366.72 %23.13 %11.15 %
201268.14 %26.07 %14.99 %
201166.16 %21.21 %16.19 %
201068.77 %25.61 %17.39 %
200967.51 %24.71 %16.47 %
200868.28 %23.13 %17.09 %
200768.91 %22.11 %16.95 %
200668.6 %21.7 %15.12 %
200567.69 %20.57 %13.97 %
200467.56 %19.89 %10.95 %

Stryker Aktienanalyse

What does Stryker do?

Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Stryker's Sales Figures

The sales figures of Stryker originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Stryker’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Stryker's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Stryker’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Stryker stock

How much revenue did Stryker generate this year?

Stryker has achieved a revenue of 22.82 B USD this year.

How much was the turnover of the company Stryker compared to the previous year?

The revenue of Stryker has increased by 11.31% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Stryker?

The revenue of Stryker is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Stryker measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Stryker so important for investors?

The revenue of Stryker is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Stryker pay?

Over the past 12 months, Stryker paid a dividend of 3.05 USD . This corresponds to a dividend yield of about 0.78 %. For the coming 12 months, Stryker is expected to pay a dividend of 3.27 USD.

What is the dividend yield of Stryker?

The current dividend yield of Stryker is 0.78 %.

When does Stryker pay dividends?

Stryker pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Stryker?

Stryker paid dividends every year for the past 34 years.

What is the dividend of Stryker?

For the upcoming 12 months, dividends amounting to 3.27 USD are expected. This corresponds to a dividend yield of 0.83 %.

In which sector is Stryker located?

Stryker is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stryker kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stryker from 10/31/2024 amounting to 0.8 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Stryker pay the last dividend?

The last dividend was paid out on 10/31/2024.

What was the dividend of Stryker in the year 2023?

In the year 2023, Stryker distributed 2.835 USD as dividends.

In which currency does Stryker pay out the dividend?

The dividends of Stryker are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Stryker stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Stryker

Our stock analysis for Stryker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stryker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.